Management of Non-Cardiac Medications Before Coronary Angiography
Continue aspirin (ASA) in all patients undergoing coronary angiography, regardless of indication, as it reduces mortality without increasing bleeding risk. 1, 2
Antiplatelet Therapy Management
Aspirin (ASA)
- Continue chronic ASA therapy through the procedure 3
- If not on chronic ASA, administer a loading dose orally before the procedure 3
- ASA continuation is strongly recommended even in patients who may require CABG, as it does not increase perioperative bleeding or transfusion requirements 1
P2Y12 Inhibitors (Clopidogrel, Ticagrelor, Prasugrel)
For Elective Coronary Angiography (Stable CAD):
- Do NOT routinely pretreat with P2Y12 inhibitors before diagnostic angiography 3
- Administer clopidogrel 600 mg loading dose in the catheterization laboratory only if PCI is performed 3
- Clopidogrel is the preferred P2Y12 inhibitor for elective PCI 3
For NSTE-ACS:
- If angiography expected ≤24 hours: Do NOT pretreat with P2Y12 inhibitors 3
- If angiography expected >24 hours: Pretreat with P2Y12 inhibitor before the procedure 3
- Exception: If high suspicion for CABG anatomy, withhold P2Y12 inhibitor even if delay >24 hours 3
If Patient Already on P2Y12 Inhibitor:
- Continue therapy through diagnostic angiography 2, 4
- If CABG is planned after angiography, follow specific discontinuation protocols (see below) 1, 2
Timing of P2Y12 Inhibitor Discontinuation Before CABG
Clopidogrel:
- Ideal interruption: 5 days before elective CABG 1, 2
- Minimum interruption for semi-urgent CABG: 48-72 hours 1, 2
- Studies show 3 days may be sufficient to mitigate bleeding risk 3
Ticagrelor:
- Ideal interruption: 5 days before elective CABG 1
- Minimum interruption for semi-urgent CABG: 48-72 hours 1
- For non-cardiac surgery: stop 3-5 days before procedure 5
Prasugrel:
- Ideal interruption: 7 days before elective CABG 1, 2
- Minimum interruption for semi-urgent CABG: 5 days 1, 2
Anticoagulation Management
If Patient on Anticoagulation Before Angiography:
Unfractionated Heparin (UFH):
- Continue through procedure and for at least 48 hours after diagnostic angiography 2, 4
- If CABG planned: Continue UFH perioperatively 2, 4
Enoxaparin:
- Continue for duration of hospitalization (up to 8 days) if given before angiography 4
- If CABG planned: Discontinue 12-24 hours before surgery and transition to UFH 2, 4
Fondaparinux:
- Continue for duration of hospitalization (up to 8 days) if given before angiography 4
- If CABG planned: Discontinue 24 hours before surgery and transition to UFH 2, 4
Bivalirudin:
- May discontinue or continue at 0.25 mg/kg/h for up to 72 hours at physician's discretion 4
- If CABG planned: Discontinue 3 hours before surgery and transition to UFH 2, 4
GP IIb/IIIa Inhibitors
Before Diagnostic Angiography:
- If already started, continue through procedure 4
- Do NOT routinely start before diagnostic angiography 4
If CABG Planned:
If PCI Performed:
- Administer for troponin-positive and high-risk patients if not already started 4
- May omit if bivalirudin used and clopidogrel 300 mg given ≥6 hours earlier 4
Non-Antithrombotic Medications
Beta-Blockers and Other Cardiac Medications
- Continue all chronic cardiac medications (beta-blockers, ACE inhibitors, ARBs, statins) through the procedure 6
- These medications should NOT be discontinued for diagnostic coronary angiography 6
Premedication with Sedatives
- Routine premedication with benzodiazepines (diazepam) and antihistamines (chlorpheniramine) is NOT recommended 7
- Studies show no benefit for anxiety or pain reduction and may increase local pain 7
- Intravenous midazolam may be administered during the procedure at operator's discretion 7
Critical Pitfalls to Avoid
- Never discontinue aspirin before diagnostic angiography - this increases mortality risk without reducing bleeding 1, 2
- Do not preload P2Y12 inhibitors for elective cases - this unnecessarily exposes patients to bleeding risk if CABG is needed 3
- Do not delay urgent CABG excessively for P2Y12 washout - experienced surgeons can proceed with 48-72 hours interruption if clinically necessary 1, 2
- Always transition fondaparinux and enoxaparin to UFH before CABG - direct continuation increases bleeding risk 2, 4